Explaining the FDA’s reasoning, Mitch Zeller, its director for tobacco products said: “The manufacturer’s data demonstrates its tobacco-flavoured products could benefit addicted adult smokers who switch to these products – either completely or with a significant reduction in cigarette consumption – by reducing their exposure to harmful chemicals.”